| Differences in cardiovascular mortality between Western and Eastern Europe - Keynote Lecture. | Cardiovascular disease in Central and Eastern Europe I | Professor Bobak |
| Longitudinal trends in cardiovascular mortality and major cardiovascular risk factors in the Czech population in 1985 to 2007/8. Czech MONICA and Czech post-MONICA Study. | Cardiovascular disease in Central and Eastern Europe I | Sir Cifkova, FESC |
| Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2008. | Cardiovascular disease in Central and Eastern Europe I | Dr Bruthans, FESC |
| Explaining the decrease in coronary heart disease mortality rates in Poland, 1990-2005. | Cardiovascular disease in Central and Eastern Europe II | Dr Bandosz |
| After the success story: what are the challenges for the future? | Cardiovascular prevention and rehabilitation, a lifelong challenge | Professor Graham, FESC |
| Is it ever too late for cardiovascular prevention and rehabilitation? | Cardiovascular prevention and rehabilitation, a lifelong challenge | Professor Gohlke, FESC |
| Perception of CVD risk factors by different stake-holders. | Guidelines on CVD Prevention - From basic science to implementation | Professor Reiner, FESC |
| Responses of blood lipids to aerobic and resistance type of exercise. | Prevention in adults: is it good to know? | Professor Sidossis |
| Exercise as a mean to control low grade systemic inflammation. | Prevention in adults: is it good to know? | Dr Ferraz |
| Adherance to health behaviour advice in heart failure. | Prevention in adults: is it good to know? | Professor Pogosova |
| Common beliefs and their effect on activity levels in patients with angina. | Prevention in adults: is it good to know? | Dr Furze |
| Prevalence and clinical correlates of ECG patterns in adolescent athletes. | Cardiovascular adaptation to exercise in children | Dr Quattrini |
| Physiological upper limits of cardiac dimensions in adolescent athletes. | Cardiovascular adaptation to exercise in children | Dr Papadakis |
| Too young to compete? Relevance to genes and other considerations. | Cardiovascular adaptation to exercise in children | Professor Heidbuchel, FESC |
| Exercise testing in the elderly: same setup - different approach? | Exercise testing and training in the elderly - A new challenge in cardiac rehabilitation | Dr Mezzani, FESC |
| Depression, isolation, social support and cardiovascular rehabilitation in older adults. | Exercise testing and training in the elderly - A new challenge in cardiac rehabilitation | Professor Rauch |
| What is the evidence for age-related differences in the cardiovascular response to training programmes in elderly people? | Exercise testing and training in the elderly - A new challenge in cardiac rehabilitation | Associate Professor Gielen, FESC |
| Who is at risk and what are the appropriate screening tools in relation to risk? | Prevention of diabetes - Possible and feasible? | Professor Tuomilehto, FESC |
| Drugs for the prevention of diabetes - are there benefits beyond retarding the onset of diabetes. | Prevention of diabetes - Possible and feasible? | Professor Schnell |
| Is bariatric surgery the final solution? | Prevention of diabetes - Possible and feasible? | Associate Professor Torgerson |
| Fit or fat? Adipocity, physical activity, insulin resistance and blood pressure in children. | Couch kids: what can be done to counter the epidemic? | Professor Nassis |
| Behaviour interventions to promote physical activity and proper nutrition among children. | Couch kids: what can be done to counter the epidemic? | Associate Professor Palmeira |
| Screening for cardiovascular disease in the elderly. | At last - too old for prevention? | Professor Kostka |
| Telomere biology, vascular aging and coronary artery disease. | Insights into cardiovascular aging | Dr Vasa-Nicotera |
| Presentation of the Awardee. | Frederick H. Epstein Memorial Lecture | Professor De Sutter, FESC |
| QOL and mortality in coronary patients. | Health related quality of life or mortality: which is clinically more useful as an outcome measure? | Ms Pelle |
| QOL and mortality in heart failure patients. | Health related quality of life or mortality: which is clinically more useful as an outcome measure? | Professor Zdrenghea, FESC |
| The HeartQol Questionnaire: methodological and analytical approaches. | Health related quality of life or mortality: which is clinically more useful as an outcome measure? | Associate Professor Hofer, FESC |
| The HeartQol Questionnaire: introducing a common core heart-related quality of life instrument. | Health related quality of life or mortality: which is clinically more useful as an outcome measure? | Professor Oldridge, FESC |
| Have socioeconomic differences in coronary risk factors changed over 20 years? Results from a population-based study of men between 1978-80 and 1998-2000. | Young Investigators Award | Dr Ramsay |
| Is high ankle-brachial index predictor of increased cardiovascular risk? The Czech post-MONICA study. | Young Investigators Award | Dr Wohlfahrt |
| Polymorphism of the alpha2a adrenoreceptor gene and aerobic power in coronary artery disease. | Young Investigators Award | Mr Onkelinx |
| Minor symptoms of depression in patients with congenital heart disease have a larger impact on quality of life than severely limited exercise capacity. | Young Investigators Award | Mr Mueller |
| Ethnic differences in the electrocardiographic repolarisation patterns in elite male athletes and short-term outcomes. | Young Investigators Award | Dr Papadakis |
| Fatal versus total events in risk assessment models. | Risk assessment models: what is to come? | Dr Jousilahti |
| Role of biomarkers in improving risk assessment models. | Risk assessment models: what is to come? | Dr Olsen |
| Role of imaging in improving risk assessment models. | Risk assessment models: what is to come? | Professor Grobbee, FESC |
| Risk assessment models: application in clinical practice. | Risk assessment models: what is to come? | Professor De Backer, EFESC |
| Cardiac adaptation in veteran athletes. | Too old to play? | Dr Hood |
| What are the long-term cardiac implications of participating in high intensity sports? | Too old to play? | Dr Bjornstad, FESC |
| Is there a role for pre-participation screening in middle aged athletes? | Too old to play? | Associate Professor Borjesson, FESC |
| The role of patients' intentions and beliefs in choosing to attend cardiac rehabilitation. | Does it matter what patients think? Patients' beliefs about heart disease and rehabilitation | Associate Professor Benzer, FESC |
| Illness perceptions as predictors of self-care behaviour in heart failure patients. | Does it matter what patients think? Patients' beliefs about heart disease and rehabilitation | Dr Morgan |
| The importance of knowledge and beliefs for adherence to health behaviour advice in heart failure. | Does it matter what patients think? Patients' beliefs about heart disease and rehabilitation | Dr Garcia Porrero, FESC |
| Exercise guidelines in adolescents and young adults with congenital heart disease. | Exercise recommendations in athletes | Dr Hirth FESC |
| Exercise guidelines in individuals with cardiomyopathy. | Exercise recommendations in athletes | Professor Sharma, FESC |
| Exercise guidelines in asymptomatic older athletes. | Exercise recommendations in athletes | Professor Vanhees, FESC |
| Exercise guidelines in athletes following cardiac surgery. | Exercise recommendations in athletes | Dr Panhuyzen-Goedkoop, EC |
| Diet and lifestyle in the prevention of CVD: where is the biggest bang for the buck? | Frederick H. Epstein Memorial Lecture | Professor Rimm |